关于我们
SanoBio Therapeutics is taking a novel peptide molecule proven to be highly effective at treating cutaneous wounds and commercializing it for the treatment of diabetic ulcers. Our immediate focus is to conduct further animal trials before filing an Investigational New Drug Application (IND) with the Federal Food and Drug Administration. Our long-term vision is to provide a safe and effective therapy for wound healing worldwide.
- 网站
-
https://www.sanobio.com
SanoBio Therapeutics的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 总部
- Ann Arbor，MI
- 类型
- 私人持股
- 创立
- 2009
地点
-
主要
获取路线
1220 S University Ave Suite 211
US，MI，Ann Arbor，48104